Gülten, E. Et Al. 2022. SARS-CoV-2 Infection may be Prevented with Cytochrome Inhibitors: Cobicistat and Ritonavir. Infectious diseases and clinical microbiology (Online) , vol.4, no.3 , 185-191.

Gülten, E., Çelik, İ., Beşikci, A., Çınar, G., Akdemir Kalkan, İ., Kılcıgil, G., ... Memikoğlu, K. O.(2022). SARS-CoV-2 Infection may be Prevented with Cytochrome Inhibitors: Cobicistat and Ritonavir. Infectious diseases and clinical microbiology (Online) , vol.4, no.3, 185-191.

Gülten, EZGİ Et Al. "SARS-CoV-2 Infection may be Prevented with Cytochrome Inhibitors: Cobicistat and Ritonavir," Infectious diseases and clinical microbiology (Online) , vol.4, no.3, 185-191, 2022

Gülten, EZGİ Et Al. "SARS-CoV-2 Infection may be Prevented with Cytochrome Inhibitors: Cobicistat and Ritonavir." Infectious diseases and clinical microbiology (Online) , vol.4, no.3, pp.185-191, 2022

Gülten, E. Et Al. (2022) . "SARS-CoV-2 Infection may be Prevented with Cytochrome Inhibitors: Cobicistat and Ritonavir." Infectious diseases and clinical microbiology (Online) , vol.4, no.3, pp.185-191.

@article{article, author={EZGİ GÜLTEN Et Al. }, title={SARS-CoV-2 Infection may be Prevented with Cytochrome Inhibitors: Cobicistat and Ritonavir}, journal={Infectious diseases and clinical microbiology (Online)}, year=2022, pages={185-191} }